Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Jay H Traverse

October 15, 2015

REGISTER for free or LOG IN to view this content

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presentation

TCT 2015

Up Next

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Bioartificial Matrices, Which Are Available and Versatile!

Presenter: Felipe Prosper

October 15, 2015

More slides +

Presentation TCT 2015

Use of Endoanchors to Prevent or Treat Gutter-Related Endoleaks After Use of Chimneys and Parallel Grafts

Presenter: Zvonimir Krajcer

October 15, 2015

Presentation TCT 2015

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Thierry Lefevre

October 15, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.